Prostate Cancer Reports

Volume 2 Number 7
 July 2014

Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Number 7, July 2014


Diagnosis and evaluation
Etiology and pathogenesis
Integrative medicine
Overall management
Prognosis and outcome

Barchetti F, Panebianco V.
Multiparametric MRI for Recurrent Prostate Cancer Post Radical Prostatectomy and Postradiation Therapy.
Biomed Res Int. 2014;2014:316272. Epub 2014 May 25.
Abstract | Full text | Related citations


Shi X, Gipp J, Dries M, Bushman W.
Prostate progenitor cells proliferate in response to castration.
Stem Cell Res. 2014 Apr 22;13(1):154-163. doi: 10.1016/j.scr.2014.04.005. [Epub ahead of print]
Abstract | Full text | Related citations


Chesnokov V, Gong B, Sun C, Itakura K.
Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation.
Cancer Cell Int. 2014 May 28;14:45. doi: 10.1186/1475-2867-14-45. eCollection 2014.
Abstract | Full text | Related citations

Chrubasik-Hausmann S, Vlachojannis C, Zimmermann B.
Pomegranate Juice and Prostate Cancer: Importance of the Characterisation of the Active Principle.
Phytother Res. 2014 Jun 3. doi: 10.1002/ptr.5181. [Epub ahead of print]
Abstract | Related citations


Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood W 3rd, Salner AL, Zelefsky MJ, Aragon-Ching JB, Slovin SF, Wittmann DA, Hoyt MA, Sinibaldi VJ, Chodak G, Pratt-Chapman ML, Cowens-Alvarado RL.
American Cancer Society prostate cancer survivorship care guidelines.
CA Cancer J Clin. 2014 Jun 10. doi: 10.3322/caac.21234. [Epub ahead of print]
Abstract | Full text | Patient page | Erratum Related citations

Comprehensive outcome

Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Maucieri A, Gerardi MA, Vischioni B, Cambria R, Garibaldi C, Cattani F, Vavassori A, Matei DV, Musi G, De Cobelli O, Orecchia R.
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy.
BJU Int. 2013 Oct 29. doi: 10.1111/bju.12530. Epub 2014 Feb 4.
Abstract | Full text | Related citations

Tuppin P, Samson S, Fagot-Campagna A, Lukacs B, Alla F; CNAMTS scientific board members, Paccaud F, Thalabard JC, Vicaut E, Vidaud M, Millat B.
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality.
BMC Urol. 2014 Jun 13;14(1):48. doi: 10.1186/1471-2490-14-48.
Abstract | Full text | Related citations


Turo R, Forster JA, West RM, Prescott S, Paul AB, Cross WR.
Do prostate cancer nomograms give accurate information when applied to European patients?
Scand J Urol. 2014 Jun 2:1-9. [Epub ahead of print]
Abstract | Related citations

PCa-specific mortality

Albertsen P.
Radical prostatectomy reduces prostate cancer-specific mortality among men with intermediate-grade disease, but provides minimal benefit for men with low-grade and high-grade disease.
Evid Based Med. 2014 Jun 10. pii: ebmed-2014-110013. doi: 10.1136/eb-2014-110013. [Epub ahead of print]
Abstract | Full text | Related citations

Gandaglia G, Karakiewicz PI, Abdollah F, Becker A, Roghmann F, Sammon JD, Kim SP, Perrotte P, Briganti A, Montorsi F, Trinh QD, Sun M.
The effect of age at diagnosis on prostate cancer mortality: A grade-for-grade and stage-for-stage analysis.
Eur J Surg Oncol. 2014 May 22. pii: S0748-7983(14)00446-6. doi: 10.1016/j.ejso.2014.05.001. [Epub ahead of print]
Abstract | Related citations

Phillips JG, Aizer AA, Chen MH, Zhang D, Hirsch MS, Richie JP, Tempany CM, Williams S, Hegde JV, Loffredo MJ, D'Amico AV.
The Effect of Differing Gleason Scores at Biopsy on the Odds of Upgrading and the Risk of Death From Prostate Cancer.
Clin Genitourin Cancer. 2014 Mar 3. pii: S1558-7673(14)00041-X. doi: 10.1016/j.clgc.2014.02.008. [Epub ahead of print]
Abstract | Related citations

Risk factors

Kozminski MA, Palapattu GS, Mehra R, Montgomery JS, Weizer AZ, Skolarus TA, Hollenbeck BK, Miller DC, He C, Tomlins S, Montie JE, Feng FY, Wood DP, Kunju LP, Morgan TM.
Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer.
Urology. 2014 Jun 20. pii: S0090-4295(14)00437-3. doi: 10.1016/j.urology.2014.03.037. [Epub ahead of print]
Abstract | Related citations

Gleason score

Eroglu M, Doluoglu OG, Sarici H, Telli O, Ozgur BC, Bozkurt S.
Does the time from biopsy to radical prostatectomy affect Gleason score upgrading in patients with clinical t1c prostate cancer?
Korean J Urol. 2014 Jun;55(6):395-9. doi: 10.4111/kju.2014.55.6.395. Epub 2014 Jun 16.
Abstract | Full text | Related citations

Sarici H, Telli O, Yigitbasi O, Ekici M, Ozgur BC, Yuceturk CN, Eroglu M.
Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6.
Can Urol Assoc J. 2014 May;8(5-6):E342-6. doi: 10.5489/cuaj.1499.
Abstract | Full text | Related citations

Special topics


Ishak-Howard MB, Okoth LA, Cooney KA.
Statin Use and the Risk of Recurrence After Radical Prostatectomy in a Cohort of Men With Inherited and/or Early-onset Forms of Prostate Cancer.
Urology. 2014 Jun;83(6):1356-61. doi: 10.1016/j.urology.2014.02.015. Epub 2014 Apr 16.
Abstract | Related citations

Tural D, Yuce D, Kilickap S.
Mortality in Prostate Cancer and Use of Statins.
J Clin Oncol. 2014 Jun 9. pii: JCO.2013.54.3264. [Epub ahead of print]
Abstract | Full text | Related citations

Treatment comparison

Tozawa K, Yasui T, Umemoto Y, Mizuno K, Okada A, Kawai N, Takahashi S, Kohri K.
Pitfalls of robot-assisted radical prostatectomy: A comparison of positive surgical margins between robotic and laparoscopic surgery.
Int J Urol. 2014 Jun 10. doi: 10.1111/iju.12492. [Epub ahead of print]
Abstract | Related citations